SCHEMBL18019282

SCHEMBL18019282

CNc1nc(-c2ccc(C(=O)O)cc2)ccc1C(C)=O

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 6/20 0.44
RAB9A P51151 5/20 0.42
KDM4E B2RXH2 4/20 0.42
RXFP1 Q9HBX9 1/20 0.42
POLB P06746 1/20 0.42
GAA P10253 1/20 0.42
HTT P42858 1/20 0.42
ALDH1A1 P00352 2/20 0.42
NPC1 O15118 3/20 0.41
CAMK2D Q13557 2/20 0.41
LDHA P00338 1/20 0.41
LDHB P07195 1/20 0.41
CHEK1 O14757 2/20 0.40
TP53 P04637 1/20 0.40
RARA P10276 1/20 0.39
RARB P10826 1/20 0.39
MAPK8 P45983 1/20 0.38
PIK3CG P48736 1/20 0.38
CAMKK2 Q96RR4 1/20 0.38
CSNK2A2 P19784 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20256988 0.85 SMN1; SMN2 (0.46) SMN1; SMN2RAB9AKDM4ERXFP1POLB
SCHEMBL18019293 0.85 LDHA (0.52) GAAALDH1A1LDHALDHB
SCHEMBL20256989 0.85 LDHA (0.46) SMN1; SMN2RAB9AKDM4ERXFP1POLB
SCHEMBL15131382 0.85 SMN1; SMN2 (0.41) SMN1; SMN2RAB9AKDM4ERXFP1POLB
SCHEMBL20256902 0.85 SMN1; SMN2 (0.45) SMN1; SMN2RAB9AKDM4ERXFP1POLB
SCHEMBL10212526 0.83 SMN1; SMN2 (0.40) SMN1; SMN2RAB9AKDM4ERXFP1POLB
SCHEMBL899974 0.76 ABCG2 (0.44) SMN1; SMN2RAB9AKDM4ERXFP1GAA
SCHEMBL19928396 0.72 LDHA (0.46) SMN1; SMN2RAB9AKDM4ERXFP1POLB
SCHEMBL20256987 0.72 SMN1; SMN2 (0.45) SMN1; SMN2RAB9AKDM4ERXFP1POLB
SCHEMBL12647214 0.71 KDM4E (0.49) SMN1; SMN2RAB9AKDM4EHTTALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10294225-B2 N1-pyrazolospiroketone acetyl-CoA carboxylase inhibitors PFIZER INC. (US) 2019-05-21 US disclosed
US-20180162858-A1 N1-PYRAZOLOSPIROKETONE ACETYL-CoA CARBOXYLASE INHIBITORS PFIZER INC. (US) 2018-06-14 US disclosed
EP-2621493-B1 N1-PYRAZOLOSPIROKETONE ACETYL-CoA CARBOXYLASE INHIBITORS PFIZER (US) 2016-08-17 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10294225-B2 N1-pyrazolospiroketone acetyl-CoA carboxylase inhibitors ACACA, ACACB, PC SMN1; SMN2 2926/4885RAB9A 3773/4885KDM4E 1995/4885
US-20180162858-A1 N1-PYRAZOLOSPIROKETONE ACETYL-CoA CARBOXYLASE INHIBITORS ACACA, ACACB, PC SMN1; SMN2 2926/4885RAB9A 3773/4885KDM4E 1995/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.